271 related articles for article (PubMed ID: 10868649)
1. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.
Ojo AO; Meier-Kriesche HU; Hanson JA; Leichtman AB; Cibrik D; Magee JC; Wolfe RA; Agodoa LY; Kaplan B
Transplantation; 2000 Jun; 69(11):2405-9. PubMed ID: 10868649
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Sollinger HW
Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
Knight SR; Russell NK; Barcena L; Morris PJ
Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178
[TBL] [Abstract][Full Text] [Related]
4. Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients.
Meier-Kriesche HU; Ojo AO; Leichtman AB; Punch JD; Hanson JA; Cibrik DM; Kaplan B
J Am Soc Nephrol; 2000 Dec; 11(12):2366-2370. PubMed ID: 11095660
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients.
Meier-Kriesche HU; Morris JA; Chu AH; Steffen BJ; Gotz VP; Gordon RD; Kaplan B
Nephrol Dial Transplant; 2004 Nov; 19(11):2864-9. PubMed ID: 15496562
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Mycophenolate Mofetil Acute Renal Rejection Study Group
Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
[TBL] [Abstract][Full Text] [Related]
8. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival.
Meier-Kriesche HU; Ojo AO; Leichtman AB; Magee JC; Rudich SM; Hanson JA; Cibrik DM; Kaplan B
Transplantation; 2001 Feb; 71(3):398-401. PubMed ID: 11233900
[TBL] [Abstract][Full Text] [Related]
9. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
[TBL] [Abstract][Full Text] [Related]
10. The effect of mycophenolate mofetil and azathioprine dose on renal allograft outcome in the United kingdom.
Shah S; Collett D; Johnson R; Raftery M; Rudge C; Yaqoob MM
Transplantation; 2008 Oct; 86(8):1035-42. PubMed ID: 18946340
[TBL] [Abstract][Full Text] [Related]
11. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.
Palmer SM; Baz MA; Sanders L; Miralles AP; Lawrence CM; Rea JB; Zander DS; Edwards LJ; Staples ED; Tapson VF; Davis RD
Transplantation; 2001 Jun; 71(12):1772-6. PubMed ID: 11455257
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.
Meier-Kriesche HU; Steffen BJ; Hochberg AM; Gordon RD; Liebman MN; Morris JA; Kaplan B
Transplantation; 2003 Apr; 75(8):1341-6. PubMed ID: 12717227
[TBL] [Abstract][Full Text] [Related]
13. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
[TBL] [Abstract][Full Text] [Related]
14. Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients.
Vasquez EM; Sifontis NM; Pollak R; Benedetti E
Clin Transplant; 2001 Aug; 15(4):253-7. PubMed ID: 11683819
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
Tsai MK; Hu RH; Lee CJ; Lee PH
J Formos Med Assoc; 2002 Sep; 101(9):616-21. PubMed ID: 12645188
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
Transplantation; 1999 Aug; 68(3):391-6. PubMed ID: 10459543
[TBL] [Abstract][Full Text] [Related]
17. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.
David KM; Morris JA; Steffen BJ; Chi-Burris KS; Gotz VP; Gordon RD
Clin Transplant; 2005 Apr; 19(2):279-85. PubMed ID: 15740568
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation.
Wüthrich RP; Cicvara S; Ambühl PM; Binswanger U
Nephrol Dial Transplant; 2000 Aug; 15(8):1228-31. PubMed ID: 10910450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
